Learning Objectives:

  1. At the conclusion of this activity, participants will be able to Understand current epidemiology of RSV in the United States.
  2. At the conclusion of this activity, participants will be able to Review current state of RSV prevention and treatment.
  3. At the conclusion of this activity, participants will be able to Appreciate new and evolving interventions for the prevention of RSV disease — including vaccines and newer monoclonal antibodies.
Session date: 
Monday, August 9, 2021 - 12:00pm to 1:00pm
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Stephen Schrantz, MD